Uncategorized

Novartis stays ‘geography-agnostic’ in dealmaking amid flurry of China deals

Published

2 weeks ago

on

Novartis will continue to be on the lookout for bolt-on deals below $2 billion, CEO Vas Narasimhan said Tuesday on the pharma’s second quarter earnings call—though major pickups aren’t completely off the table.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version